During 2021–2022, 113 persons traveled on commercial flights while they were infectious with clade II mpox. Among 1,046 traveler contacts followed by U.S. public health agencies, CDC identified no secondary cases.
What are the implications for public health practice?
Traveling on a flight with a person with mpox does not appear to constitute an exposure risk or warrant routine contact tracing activities.
Hmm... guess none of these folks joined the mile high club during the trip.
No comments:
Post a Comment